Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development
Zev A. Binder(University of Pennsylvania), Amy Haseley Thorne(Ludwig Cancer Research), Spyridon Bakas(University of Pennsylvania), E. Paul Wileyto(University of Pennsylvania), Michel Bilello(University of Pennsylvania), Hamed Akbari(University of Pennsylvania), Saima Rathore(University of Pennsylvania), Sung Min Ha(University of Pennsylvania), Logan Zhang(University of Pennsylvania), Cole Ferguson(Washington University in St. Louis), Sonika Dahiya(Washington University in St. Louis), Wenya Linda Bi(Woman's Hospital), David A. Reardon(Center for Neuro-Oncology), Ahmed Idbaïh(Centre National de la Recherche Scientifique), Joerg Felsberg(Heinrich Heine University Düsseldorf), Bettina Hentschel(Leipzig University), Michael Weller(University of Zurich), Stephen Bagley(University of Pennsylvania), Jennifer J.D. Morrissette(University of Pennsylvania), MacLean P. Nasrallah(University of Pennsylvania), Jianhui Ma(Ludwig Cancer Research), Ciro Zanca(Ludwig Cancer Research), Andrew M. Scott(La Trobe University), Laura Orellana(Stockholm University), Christos Davatzikos(University of Pennsylvania), Frank B. Furnari(Ludwig Cancer Research), Donald M. O’Rourke(University of Pennsylvania)
Cited by 171Open Access
Abstract
Related Papers
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Ryo Nishikawa, Xiang-Dong Ji, R. Christopher Harmon et al.|Proceedings of the National Academy of Sciences|1994|931